000 01251 a2200337 4500
005 20250515094408.0
264 0 _c20080201
008 200802s 0 0 eng d
022 _a1710-3568
024 7 _a10.2310/6620.2007.06037
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchalock, Peter C
245 0 0 _aAcneiform reaction to erlotinib.
_h[electronic resource]
260 _bDermatitis : contact, atopic, occupational, drug
_cDec 2007
300 _a230-1 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAcneiform Eruptions
_xetiology
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aDrug Eruptions
_xetiology
650 0 4 _aErlotinib Hydrochloride
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProtein Kinase Inhibitors
_xadministration & dosage
650 0 4 _aQuinazolines
_xadministration & dosage
700 1 _aZug, Kathryn A
773 0 _tDermatitis : contact, atopic, occupational, drug
_gvol. 18
_gno. 4
_gp. 230-1
856 4 0 _uhttps://doi.org/10.2310/6620.2007.06037
_zAvailable from publisher's website
999 _c17537934
_d17537934